Docusign (NASDAQ:DOCU – Get Free Report) posted its earnings results on Tuesday. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.06, FiscalAI reports. The firm had revenue of $836.86 million during the quarter, compared to analysts’ expectations of $828.23 million. Docusign had a net margin of 9.57% and a return on equity of 15.02%. The business’s revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.86 EPS.
Docusign Stock Performance
Shares of DOCU stock traded up $0.72 on Tuesday, reaching $47.54. 7,859,945 shares of the company were exchanged, compared to its average volume of 4,804,390. Docusign has a 1 year low of $40.16 and a 1 year high of $94.67. The business has a 50-day moving average price of $51.11 and a 200 day moving average price of $64.46. The company has a market cap of $9.52 billion, a price-to-earnings ratio of 33.24, a P/E/G ratio of 2.05 and a beta of 1.03.
Insider Transactions at Docusign
In other Docusign news, CEO Allan C. Thygesen sold 26,250 shares of the stock in a transaction that occurred on Friday, January 9th. The stock was sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the completion of the transaction, the chief executive officer owned 142,261 shares of the company’s stock, valued at $9,901,365.60. This represents a 15.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $67.05, for a total value of $402,300.00. Following the completion of the transaction, the executive owned 68,970 shares in the company, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 74,810 shares of company stock worth $5,115,951 in the last three months. 1.66% of the stock is owned by corporate insiders.
Institutional Trading of Docusign
Docusign News Roundup
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Q4 earnings and revenue beat consensus (EPS $1.01 vs. $0.95 estimate), showing upside to recent expectations — this is the primary near‑term catalyst supporting the stock. DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates
- Positive Sentiment: Company raised its share buyback authorization by $2.0 billion — a direct capital‑allocation move that supports EPS and can buoy the stock. Docusign Announces Fourth Quarter and Fiscal Year 2026 Financial Results; Announces $2.0 Billion Increase to Share Repurchase Program
- Positive Sentiment: Board addition of an AI‑focused independent director and ongoing AI product integrations are being viewed as strategic positives that could drive future subscription expansion beyond e‑signatures. The Bull Case For DocuSign (DOCU) Could Change Following New AI-Focused Director Appointment – Learn Why
- Neutral Sentiment: Analysts and previews focused on key Q4 metrics and guidance comparisons; these items will matter for next‑quarter sentiment but are read as routine post‑earnings analysis. DocuSign (DOCU) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Neutral Sentiment: Marketwide drivers (Fed/FOMC meeting, macro data, big‑tech events) are creating broader volatility that could amplify DOCU moves short‑term. Markets Wait for Fed’s FOMC Meeting
- Negative Sentiment: Bearish commentary warns DOCU remains vulnerable after a steep multi‑month pullback; some analysts flag valuation and downside risk if execution or guidance disappoints. DocuSign stock price at risk of a steep crash after earnings on March 17
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on DOCU. Piper Sandler decreased their price objective on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Jefferies Financial Group lowered Docusign from a “buy” rating to a “hold” rating and cut their price target for the company from $105.00 to $45.00 in a research note on Monday, February 23rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a report on Tuesday, March 10th. Royal Bank Of Canada lowered their price target on Docusign from $95.00 to $70.00 and set a “sector perform” rating on the stock in a research report on Monday, January 5th. Finally, Citigroup reissued a “market outperform” rating on shares of Docusign in a report on Monday, March 2nd. Five equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to MarketBeat.com, Docusign currently has an average rating of “Hold” and an average target price of $78.80.
Read Our Latest Stock Report on DOCU
Docusign Company Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Further Reading
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
